A citation-based method for searching scientific literature

Mohammad Sheibani, Yaser Azizi, Maryam Shayan, Sadaf Nezamoleslami, Faezeh Eslami, Mohammad Hadi Farjoo, Ahmad Reza Dehpour. Cardiovasc Toxicol 2022
Times Cited: 12







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management.
Pushkar Singh Rawat, Aiswarya Jaiswal, Amit Khurana, Jasvinder Singh Bhatti, Umashanker Navik. Biomed Pharmacother 2021
72
25

Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tomonori Tadokoro, Masataka Ikeda, Tomomi Ide, Hiroko Deguchi, Soichiro Ikeda, Kosuke Okabe, Akihito Ishikita, Shouji Matsushima, Tomoko Koumura, Ken-Ichi Yamada,[...]. JCI Insight 2020
164
25

Oxidative stress injury in doxorubicin-induced cardiotoxicity.
Mei Songbo, Hong Lang, Cai Xinyong, Xiao Bin, Zhang Ping, Shao Liang. Toxicol Lett 2019
181
25

Regulated cell death pathways in doxorubicin-induced cardiotoxicity.
Effimia Christidi, Liam R Brunham. Cell Death Dis 2021
92
25

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
16

Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study.
Fazile Nur Ekinci Akdemir, Serkan Yildirim, Fatih Mehmet Kandemir, Ayhan Tanyeli, Sefa Küçükler, Muhammed Bahaeddin Dortbudak. Arch Physiol Biochem 2021
9
22

Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats.
Ava Soltani Hekmat, Zahra Navabi, Hiva Alipanah, Kazem Javanmardi. Hum Exp Toxicol 2021
6
33


Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats.
Mohammad Sheibani, Sadaf Nezamoleslami, Hedyeh Faghir-Ghanesefat, Amir Hossein Emami, Ahmad Reza Dehpour. Cancer Chemother Pharmacol 2020
26
16

A comprehensive review on time-tested anticancer drug doxorubicin.
Sruthi Sritharan, Nageswaran Sivalingam. Life Sci 2021
49
16


Cardiomyocyte death in doxorubicin-induced cardiotoxicity.
Yi-Wei Zhang, Jianjian Shi, Yuan-Jian Li, Lei Wei. Arch Immunol Ther Exp (Warsz) 2009
277
16

Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Mingchuan Li, Valentina Sala, Maria Chiara De Santis, James Cimino, Paola Cappello, Nicola Pianca, Anna Di Bona, Jean Piero Margaria, Miriam Martini, Edoardo Lazzarini,[...]. Circulation 2018
104
16

Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart.
Zeynep Erdogmus Ozgen, Meral Erdinc, İlker Kelle, Levent Erdinc, Yusuf Nergiz. Hum Exp Toxicol 2022
2
100

Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation.
Danlei Li, Xiaoman Liu, Wenhu Pi, Yang Zhang, Lei Yu, Cheng Xu, Zhenzhu Sun, Jianjun Jiang. Front Pharmacol 2022
12
16

Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage.
Ahmad Syukri, Budu, Mochammad Hatta, Muzakkir Amir, Mohammad Saifur Rohman, Idar Mappangara, Cahyono Kaelan, Siti Wahyuni, Agussalim Bukhari, Ade Rifka Junita,[...]. Ann Med Surg (Lond) 2022
5
40

Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy.
Filipa S Carvalho, Ana Burgeiro, Rita Garcia, António J Moreno, Rui A Carvalho, Paulo J Oliveira. Med Res Rev 2014
310
16

Ferroptosis as a target for protection against cardiomyopathy.
Xuexian Fang, Hao Wang, Dan Han, Enjun Xie, Xiang Yang, Jiayu Wei, Shanshan Gu, Feng Gao, Nali Zhu, Xiangju Yin,[...]. Proc Natl Acad Sci U S A 2019
648
16

Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer.
Zongguang Tai, Jinyuan Ma, Jianing Ding, Huijun Pan, Rongrong Chai, Congcong Zhu, Zhen Cui, Zhongjian Chen, Quangang Zhu. Int J Nanomedicine 2020
16
8


Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
Qingdi Quentin Li, Gangduo Wang, Eddie Reed, Lan Huang, Christopher F Cuff. Basic Clin Pharmacol Toxicol 2010
43
8

Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells.
Christopher H Stuart, Ravi Singh, Thomas L Smith, Ralph D'Agostino, David Caudell, K C Balaji, William H Gmeiner. Nanomedicine (Lond) 2016
20
8

Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer.
Jakub Ptacek, Dong Zhang, Liming Qiu, Sven Kruspe, Lucia Motlova, Petr Kolenko, Zora Novakova, Shambhavi Shubham, Barbora Havlinova, Petra Baranova,[...]. Nucleic Acids Res 2020
5
20

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
Omid C Farokhzad, Jianjun Cheng, Benjamin A Teply, Ines Sherifi, Sangyong Jon, Philip W Kantoff, Jerome P Richie, Robert Langer. Proc Natl Acad Sci U S A 2006
8

Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer.
Wenjin Xu, Imtiaz A Siddiqui, Minakshi Nihal, Srikanth Pilla, Kimberly Rosenthal, Hasan Mukhtar, Shaoqin Gong. Biomaterials 2013
140
8

Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines.
Arezou Rabzia, Mozafar Khazaei, Zahra Rashidi, Mohammad Rasoul Khazaei. Iran J Pharm Res 2017
16
8

Advances in the Application of Modified Nucleotides in SELEX Technology.
O M Antipova, E G Zavyalova, A V Golovin, G V Pavlova, A M Kopylov, R V Reshetnikov. Biochemistry (Mosc) 2018
9
11

G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Paula J Bates, Elsa M Reyes-Reyes, Mohammad T Malik, Emily M Murphy, Martin G O'Toole, John O Trent. Biochim Biophys Acta Gen Subj 2017
148
8

An Aptamer for Broad Cancer Targeting and Therapy.
Bethany Powell Gray, Xirui Song, David S Hsu, Christina Kratschmer, Matthew Levy, Ashley P Barry, Bruce A Sullenger. Cancers (Basel) 2020
6
16

Aptamers as therapeutics.
Anthony D Keefe, Supriya Pai, Andrew Ellington. Nat Rev Drug Discov 2010
8


Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges.
Fen He, Nachuan Wen, Daipeng Xiao, Jianhua Yan, Hongjie Xiong, Shundong Cai, Zhenbao Liu, Yanfei Liu. Curr Med Chem 2020
60
8

Sequential Release of Pooled siRNAs and Paclitaxel by Aptamer-Functionalized Shell-Core Nanoparticles to Overcome Paclitaxel Resistance of Prostate Cancer.
Qianqian Guo, Yang Dong, Yanhua Zhang, Hao Fu, Chuanrong Chen, Liting Wang, Xupeng Yang, Ming Shen, Jian Yu, Meiwan Chen,[...]. ACS Appl Mater Interfaces 2021
9
11

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate.
Rotimi Sheyi, Beatriz G de la Torre, Fernando Albericio. Pharmaceutics 2022
10
10

Endocrine therapy for prostate cancer.
Jan-Erik Damber. Acta Oncol 2005
36
8

[Focus on cellular pharmacology of docetaxel].
Jean-Pierre Armand. Bull Cancer 2003
7
14

Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions.
Carmelo Di Primo, Eric Dausse, Jean-Jacques Toulmé. Methods Mol Biol 2011
20
8

The efficiency of blackberry loaded AgNPs, AuNPs and Ag@AuNPs mediated pectin in the treatment of cisplatin-induced cardiotoxicity in experimental rats.
Jihan Hussein, Mehrez E El-Naggar, Moustafa M G Fouda, Osama M Morsy, Jamaan S Ajarem, Ahmed M Almalki, Ahmed A Allam, Enas Mahmoud Mekawi. Int J Biol Macromol 2020
12
8

A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery.
John C Leach, Andrew Wang, Kaiming Ye, Sha Jin. Int J Mol Sci 2016
35
8

A ruthenium-oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapy.
Luke K McKenzie, Marie Flamme, Patrick S Felder, Johannes Karges, Frederic Bonhomme, Albert Gandioso, Christian Malosse, Gilles Gasser, Marcel Hollenstein. RSC Chem Biol 2021
3
33

Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
Eunjung Kim, Yukyung Jung, Hyangtae Choi, Jaemoon Yang, Jin-Suck Suh, Yong-Min Huh, Kunhong Kim, Seungjoo Haam. Biomaterials 2010
121
8

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.
Vaishali Bagalkot, Liangfang Zhang, Etgar Levy-Nissenbaum, Sangyong Jon, Philip W Kantoff, Robert Langer, Omid C Farokhzad. Nano Lett 2007
561
8

Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression.
Xiao-Yan He, Xiao-He Ren, Yan Peng, Jian-Ping Zhang, Shu-Lun Ai, Bo-Ya Liu, Chang Xu, Si-Xue Cheng. Adv Mater 2020
47
8

Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy.
Rebecca L Best, Nichole E LaPointe, Olga Azarenko, Herb Miller, Christine Genualdi, Stephen Chih, Ben-Quan Shen, Mary Ann Jordan, Leslie Wilson, Stuart C Feinstein,[...]. Toxicol Appl Pharmacol 2021
10
10

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
Shanta Dhar, Frank X Gu, Robert Langer, Omid C Farokhzad, Stephen J Lippard. Proc Natl Acad Sci U S A 2008
620
8

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?
Christian Thomas, Martin Baunacke, Holger H H Erb, Susanne Füssel, Kati Erdmann, Juliane Putz, Angelika Borkowetz. Cancers (Basel) 2021
6
16

SELEX methods on the road to protein targeting with nucleic acid aptamers.
Payam Bayat, Rahim Nosrati, Mona Alibolandi, Houshang Rafatpanah, Khalil Abnous, Mostafa Khedri, Mohammad Ramezani. Biochimie 2018
90
8

Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.
Kyoungin Min, Hunho Jo, Kyungmi Song, Minseon Cho, Yang-Sook Chun, Sangyong Jon, Won Jong Kim, Changill Ban. Biomaterials 2011
86
8

Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates.
In-Hyun Lee, Sukyung An, Mi Kyung Yu, Ho-Keun Kwon, Sin-Hyeog Im, Sangyong Jon. J Control Release 2011
73
8

RNA aptamers targeting cancer stem cell marker CD133.
Sarah Shigdar, Liang Qiao, Shu-Feng Zhou, Dongxi Xiang, Tao Wang, Yong Li, Lee Yong Lim, Lingxue Kong, Lianhong Li, Wei Duan. Cancer Lett 2013
111
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.